Novotalk

New York, United States Founded: 2014 • Age: 12 yrs
Cloud-based tools to improve speech fluency to monitor the stuttering therapy

About Novotalk

Novotalk is a Healthcare company based in New York (United States) founded in 2014. It operates as a cloud-based tools to improve speech fluency to monitor the stuttering therapy. Novotalk offers products and services including Novotalk App and Emily Virtual Therapist. Its focus areas include HealthTech, Disease Self Management, Neurological Disorders and Therapy. Its legal entity is Novotalk Inc. Its competitors include Stamurai, Enuncia.ai, NiNiSpeech, Speechagain and Bye Bye Stuttering and 1 more; 3 of its 6 listed competitors have raised funding.

Company details

Novotalk was founded in 2014 in New York, United States, within the health technology sector. Cloud-based tools are offered to support speech fluency improvement and stuttering therapy maintenance. These tools draw from clinical expertise and user experiences to facilitate accessible fluency shaping techniques. Online practice sessions are enabled, along with real-time performance analysis and a structure for ongoing therapy to sustain results.

  • Headquarters New York, United States
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website novotalk.com
  • Social LinkedIn X Facebook
  • Legal Name Novotalk Inc
Key Metrics

Products & Services of Novotalk

Novotalk offers a comprehensive portfolio of products and services, including Novotalk App and Emily Virtual Therapist.

Novotalk App
Speech Therapy Platform

Mobile app for self-guided stuttering exercises and AI feedback.

Emily Virtual Therapist
AI Assistant

AI tool providing personalized speech practice and progress tracking.

Funding Insights of Novotalk

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of Novotalk with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2017–Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in Novotalk

Novotalk has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include MassChallenge.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Early-stage entrepreneurs are accelerated through MassChallenge's program.
–masschallenge.orgBoston, United States
Premium access

Investor details for Novotalk

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Novotalk

2 dated milestones of Novotalk across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded Novotalk is founded.
  2. Funding First funding round.

Competitors of Novotalk

Novotalk has 6 listed competitors in our database, 3 of them funded. They include Stamurai, Enuncia.ai, NiNiSpeech, Speechagain and Bye Bye Stuttering, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
stamurai.com2017Gurugram, India$457,357–
Provider of speech therapy app for disabled
enuncia.ai2022Brandenburg, Germany$159,945–
AI-powered speech therapy app for diagnostics and treatment is offered.
ninispeech.com2016Haifa, Israel––
Speech practicing app to correct stuttering
speechagain.com2017New York, United States––
AI and cloud-based tools for speech training are provided.
byebyestuttering.com2019Sofia, Bulgaria––
AI-based multilingual stuttering therapy is provided for individuals.
iyaso.ai2023Pune, India$500,000–
AI-powered solutions for speech therapy are offered by Iyaso.
Premium access

Detailed competitors of Novotalk

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Health Monitoring & Wearables

10 companies that operate in the same segment as Novotalk (Health Monitoring & Wearables), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Smart fitness equipment and streaming platforms are provided.
2011New York, New York, United StatesUSD 995.53 MUSD 2.45 B2,894
Connected devices for health, sleep, and activity monitoring are developed.
2008Moulineaux, Seine-maritime, FranceUSD 93.83 M––
Internet first brand offering wearable breast pumps
2013London, England, United KingdomUSD 157.63 M––
Metabolic health is tracked via devices and fitness platforms.
2019Bengaluru, Karnataka, IndiaUSD 163.28 MUSD 65.48 M274
Health-tracking smart rings and biosensors are developed for biometric monitoring.
2013Oulu, North Ostrobothnia, FinlandUSD 1.32 BUSD 398.5 M1,632
Wearable glucose monitoring patches are provided for real-time data tracking.
1999San Diego, California, United StatesUSD 52.5 MUSD 4.66 B10,300
AI-based mobile app tracks and predicts menstrual cycles.
2015London, England, United KingdomUSD 269 MUSD 275.25 M701
Smartphone-enabled glucometers and diabetes management apps are provided.
2015Delhi, Delhi, IndiaUSD 50.83 MUSD 2.74 M142
Provider of a fertility tracking app that doubles as birth control
2013Stockholm, SwedenUSD 99.5 M––
Diabetes management is enabled via glucose meters and mobile apps.
2010Palo Alto, California, United StatesUSD 201 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Novotalk

Novotalk was founded in 2014 and raised its 1st funding round 3 years after it was founded.

Novotalk is headquartered in New York, United States. It is registered at New York, New York, United States.

Novotalk was founded in 2014 in New York, United States, within the health technology sector. Cloud-based tools are offered to support speech fluency improvement and stuttering therapy maintenance. These tools draw from clinical expertise and user experiences to facilitate accessible fluency shaping techniques. Online practice sessions are enabled, along with real-time performance analysis and a structure for ongoing therapy to sustain results.

Novotalk's top competitors include Stamurai, Iyaso and Enuncia.ai.

Novotalk offers Novotalk App and Emily Virtual Therapist.

Novotalk has 1 investor. Key investors include MassChallenge.

Novotalk operates through Novotalk Inc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available